BioRexis Pharmaceuticals Overview

Medical ProductsCompany

Where is BioRexis Pharmaceuticals headquartered?

BioRexis Pharmaceuticals is headquartered in King of Prussia, Pennsylvania.

What sector is BioRexis Pharmaceuticals in?

BioRexis Pharmaceuticals is a medical products company.

When was BioRexis Pharmaceuticals founded?

BioRexis Pharmaceuticals was founded in 2002.

BioRexis Pharmaceuticals Corp.

3400 Horizon Drive,
King of Prussia, Pennsylvania 19406
United States,
(610) 313-4000

BioRexis Pharmaceuticals Corp. is a bio-pharmaceutical company produces biopharmaceuticals.



Try Mergr Free — See This and 221,260+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.